DIAGNOSTIC VALUE OF PROTON MAGNETIC RESONANCE SPECTROSCOPY IN THE NONINVASIVE GRADING OF SOLID GLIOMAS
- 1 November 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 65 (5) , 908-913
Abstract
OBJECTIVE. Magnetic resonance spectroscopy is widely used in addition to magnetic resonance imaging in the characterization of brain tumors. CompoundsKeywords
This publication has 23 references indexed in Scilit:
- Monovoxel 1H Magnetic Resonance Spectroscopy in the Progression of GliomasEuropean Neurology, 2007
- Myo‐Inositol: a marker of reactive astrogliosis in glial tumors?NMR in Biomedicine, 2007
- Correlation of magnetic resonance spectroscopic and growth characteristics within Grades II and III gliomasJournal of Neurosurgery, 2007
- Diagnostic impact of proton MR-spectroscopy versus image-guided stereotactic biopsyActa Neurochirurgica, 2007
- Linear discriminant analysis of brain tumour 1H MR spectra: a comparison of classification using whole spectra versus metabolite quantificationNMR in Biomedicine, 2007
- Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patientsJournal of Magnetic Resonance Imaging, 2002
- Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesionsNeuroradiology, 2002
- Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging studyJournal of Neurosurgery, 1997
- Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter studyJournal of Neurosurgery, 1996
- Estimation of metabolite concentrations from localized in vivo proton NMR spectraMagnetic Resonance in Medicine, 1993